This is a preview of subscription content, log in via an institution to check access.
Notes
with extended lymph node dissection
incremental cost-effectiveness ratio
Reference
Chongqing T, et al. Cost-Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer. PharmacoEconomics : 25 May 2013. Available from: URL: http://dx.doi.org/10.1007/s40273-013-0065-2
Rights and permissions
About this article
Cite this article
Economic implications of CLASSIC trial in China. PharmacoEcon Outcomes News 681, 5 (2013). https://doi.org/10.1007/s40274-013-0503-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0503-6